There are several aspects organizationally of how we make vaccines that have been very tough. Initially we left it to the private sector. In retrospect, that was not the best idea.
Society will benefit more from an HIV vaccine than any company will.
Conservatives may tend to believe that there isn't anything that couldn't be improved and streamlined via privatization, but this is a clear counter-example to that viewpoint.